212 related articles for article (PubMed ID: 38383515)
1. Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.
Ferrari M; Righi M; Baldan V; Wawrzyniecka P; Bulek A; Kinna A; Ma B; Bughda R; Akbar Z; Srivastava S; Gannon I; Robson M; Sillibourne J; Jha R; El-Kholy M; Amin OM; Kokalaki E; Banani MA; Hussain R; Day W; Lim WC; Ghongane P; Hopkins JR; Jungherz D; Herling M; Welin M; Surade S; Dyson M; McCafferty J; Logan D; Cordoba S; Thomas S; Sewell A; Maciocia P; Onuoha S; Pule M
Nat Commun; 2024 Feb; 15(1):1583. PubMed ID: 38383515
[TBL] [Abstract][Full Text] [Related]
2. Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies.
Maciocia PM; Wawrzyniecka PA; Philip B; Ricciardelli I; Akarca AU; Onuoha SC; Legut M; Cole DK; Sewell AK; Gritti G; Somja J; Piris MA; Peggs KS; Linch DC; Marafioti T; Pule MA
Nat Med; 2017 Dec; 23(12):1416-1423. PubMed ID: 29131157
[TBL] [Abstract][Full Text] [Related]
3. Computational discovery of binding mode of anti-TRBC1 antibody and predicted key amino acids of TRBC1.
Saetang J; Sangkhathat S; Jangphattananont N; Khopanlert W; Julamanee J; Tipmanee V
Sci Rep; 2022 Feb; 12(1):1760. PubMed ID: 35110642
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Molecular Simulations and Deep Learning Prediction of Antibodies' Recognition of TRBC1 and TRBC2.
Zeng X; Wang T; Kang Y; Bai G; Ma B
Antibodies (Basel); 2023 Sep; 12(3):. PubMed ID: 37753972
[TBL] [Abstract][Full Text] [Related]
5. Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry.
Horna P; Weybright MJ; Ferrari M; Jungherz D; Peng Y; Akbar Z; Tudor Ilca F; Otteson GE; Seheult JN; Ortmann J; Shi M; Maciocia PM; Herling M; Pule MA; Olteanu H
Blood Cancer J; 2024 Feb; 14(1):34. PubMed ID: 38424120
[TBL] [Abstract][Full Text] [Related]
6. Dimorphism in the T-cell receptor constant region affects T-cell function, phenotype and HIV outcome.
Kaewpreedee P; Boonrat P; Tansiri Y; Rowland-Jones SL; Hansasuta P
AIDS; 2019 Jul; 33(9):1421-1429. PubMed ID: 30932962
[TBL] [Abstract][Full Text] [Related]
7. TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers.
Nichakawade TD; Ge J; Mog BJ; Lee BS; Pearlman AH; Hwang MS; DiNapoli SR; Wyhs N; Marcou N; Glavaris S; Konig MF; Gabelli SB; Watson E; Sterling C; Wagner-Johnston N; Rozati S; Swinnen L; Fuchs E; Pardoll DM; Gabrielson K; Papadopoulos N; Bettegowda C; Kinzler KW; Zhou S; Sur S; Vogelstein B; Paul S
Nature; 2024 Apr; 628(8007):416-423. PubMed ID: 38538786
[TBL] [Abstract][Full Text] [Related]
8. Single Antibody Detection of T-Cell Receptor αβ Clonality by Flow Cytometry Rapidly Identifies Mature T-Cell Neoplasms and Monotypic Small CD8-Positive Subsets of Uncertain Significance.
Shi M; Jevremovic D; Otteson GE; Timm MM; Olteanu H; Horna P
Cytometry B Clin Cytom; 2020 Jan; 98(1):99-107. PubMed ID: 30972977
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms.
Berg H; Otteson GE; Corley H; Shi M; Horna P; Jevremovic D; Olteanu H
Cytometry B Clin Cytom; 2021 May; 100(3):361-369. PubMed ID: 32333725
[TBL] [Abstract][Full Text] [Related]
10. Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies.
Zhang C; Palashati H; Rong Z; Lin N; Shen L; Liu Y; Li S; Yu B; Yang W; Lu Z
Mol Cancer; 2020 Nov; 19(1):162. PubMed ID: 33218364
[TBL] [Abstract][Full Text] [Related]
11. Utility of TRBC1 Expression in the Diagnosis of Peripheral Blood Involvement by Cutaneous T-Cell Lymphoma.
Horna P; Shi M; Jevremovic D; Craig FE; Comfere NI; Olteanu H
J Invest Dermatol; 2021 Apr; 141(4):821-829.e2. PubMed ID: 33049270
[TBL] [Abstract][Full Text] [Related]
12. Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience.
Capone M; Peruzzi B; Palterer B; Bencini S; Sanna A; Puccini B; Nassi L; Salvadori B; Statello M; Carraresi A; Stefanelli S; Orazzini C; Minuti B; Caporale R; Annunziato F
Transl Oncol; 2022 Dec; 26():101552. PubMed ID: 36183675
[TBL] [Abstract][Full Text] [Related]
13. Reliable Detection of T-Cell Clonality by Flow Cytometry in Mature T-Cell Neoplasms Using TRBC1: Implementation as a Reflex Test and Comparison with PCR-Based Clonality Testing.
Waldron D; O'Brien D; Smyth L; Quinn F; Vandenberghe E
Lab Med; 2022 Jul; 53(4):417-425. PubMed ID: 35285909
[TBL] [Abstract][Full Text] [Related]
14. Anti-TRBC1 Antibody-Based Flow Cytometric Detection of T-Cell Clonality: Standardization of Sample Preparation and Diagnostic Implementation.
Muñoz-García N; Lima M; Villamor N; Morán-Plata FJ; Barrena S; Mateos S; Caldas C; Balanzategui A; Alcoceba M; Domínguez A; Gómez F; Langerak AW; van Dongen JJM; Orfao A; Almeida J
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503189
[TBL] [Abstract][Full Text] [Related]
15. Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell Malignancies.
Angelos MG; Patel RP; Ruella M; Barta SK
Transplant Cell Ther; 2024 Feb; 30(2):171-186. PubMed ID: 37866783
[TBL] [Abstract][Full Text] [Related]
16. Integration of T-cell clonality screening using TRBC-1 in lymphoma suspect samples by flow cytometry.
Castillo F; Morales C; Spralja B; Díaz-Schmidt J; Iruretagoyena M; Ernst D
Cytometry B Clin Cytom; 2024 Jan; 106(1):64-73. PubMed ID: 38010106
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing.
Nguyen PC; Nguyen T; Wilson C; Tiong IS; Baldwin K; Nguyen V; Came N; Blombery P; Westerman DA
Br J Haematol; 2024 Mar; 204(3):910-920. PubMed ID: 38098188
[TBL] [Abstract][Full Text] [Related]
18. Emerging Role of T-cell Receptor Constant β Chain-1 (TRBC1) Expression in the Flow Cytometric Diagnosis of T-cell Malignancies.
Horna P; Shi M; Olteanu H; Johansson U
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673033
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Expression of the TRBC1 in T lymphocyte tumors.
Chen M; Wang A; Liu S; Wu X; Gong M; Zhen J; Fu M; Wang H
Indian J Hematol Blood Transfus; 2021 Apr; 37(2):271-279. PubMed ID: 33867734
[TBL] [Abstract][Full Text] [Related]
20. T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies.
Janelle V; Rulleau C; Del Testa S; Carli C; Delisle JS
Front Immunol; 2020; 11():276. PubMed ID: 32153583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
